Prestige Consumer Healthcare (PBH) Institutional Ownership & 13F Filings (Q2 2026)

PBH ranks #1974 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

321 institutions disclose a position in PBH, but none treat it as a major bet — even Ariel Investments, LLC, its most concentrated holder, allocates just 2.3% of its own portfolio to it.

Blue Trust, Inc. has added to its PBH position for two straight quarters, increasing it by $65.1K to reach $78.9K today.

GHP Investment Advisors, Inc. has trimmed its PBH position for two straight quarters, cutting it by $2.5M while still holding $2.8M.

PBH is up 1.5% today, and institutions have been net buyers of $376.8M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

PBH posted net income of $172.0M over the trailing twelve months, and currently trades at a P/E of 14.1.

• Profitable — net income of $172.0M over the trailing twelve months
• Revenue declined 1.4% year over year
• Net income declined year over year, from $213.0M to $172.0M
• Generated $257.6M in positive operating cash flow
• Current ratio of 3.57x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.85x equity — within a conventional range